Interaction of the human T cell leukemia virus-I transactivator protein Tax with the host cell transcriptional machinery. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Interaction of the human T cell leukemia virus-I transactivator protein Tax with the host cell transcriptional machinery.

Diss Abstr Int [B]; 53(6):2692 1992. Unique Identifier : AIDSLINE ICDB/93690097
Matthews MH; Univ. of Colorado at Boulder


Abstract: The Tax protein, encoded by human T cell leukemia virus-I (HTLV-I), is a potent transactivator of transcription. Because several of the genes transactivated by Tax are involved in regulation of cell growth, it is thought that transactivation may contribute to viral oncogenesis. Unlike a number of other viral oncogenes, the tax gene has no obvious sequence similarity to cellular genes, and the mechanism by which the Tax protein interacts with the host cell transcriptional machinery is poorly understood. To begin to characterize the biochemical mechanism of Tax-mediated transactivation, I developed a Tax-responsive in vitro transcription system. Tax was purified from cells infected with a baculovirus expression vector. Addition of these Tax preparations to nuclear extracts from uninfected human T lymphocytes activated transcription of the HTLV-I promoter approx 10-fold. As expected, the effect of recombinant Tax was diminished in HTLV-I-infected T-lymphocyte extracts containing endogenous Tax. Transcriptional stimulatory activity copurified with the immunoreactive 40-kD Tax polypeptide on gel filtration chromatography. Only monomeric Tax was active, and it was necessary to remove aggregated Tax from preparations to obtain transcriptional stimulation. Tax-mediated transactivation in vivo has been previously shown to require 21-bp repeat-Tax responsive elements (TxREs) in the promoter DNA. Stimulation of transcription in vitro was also strongly dependent on these sequences. Since Tax does not bind directly to the TxRE, it likely acts through host cell factors. To further investigate the mechanism of Tax transactivation, I purified cellular proteins that bind the 21-bp repeat TxRE using DNA affinity chromatography. Recombinant Tax markedly increased the formation of a specific host protein-DNA complex detected in an electrophoretic mobility shift assay. These data suggest that Tax activates transcription through a direct interaction with cellular proteins that bind to the 21-bp repeat TxRE. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD92-32710.)
Keywords: Cell Transformation, Viral Gene Products, tax/*METABOLISM Human HIV Long Terminal Repeat/GENETICS HTLV-I/*GENETICS/METABOLISM HTLV-I Infections/GENETICS/METABOLISM Promoter Regions (Genetics) T-Lymphocytes/METABOLISM *Transcription, Genetic THESISKWDcelltransformation,viralgeneproducts,tax/KWDmetabolismhumanhivlongterminalrepeat/geneticshtlv-i/KWDgenetics/metabolismhtlv-iinfections/genetics/metabolismpromoterregions(genetics)t-lymphocytes/metabolismKWDtranscription,geneticthesis
930630
M9361084

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .